deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT03018535

Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy (RI-CYCLO)

A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy

Sponsor: Azienda Ospedaliera Brotzu

Updated 8 times since 2017 Last updated: May 16, 2019 Started: Jan 31, 2012 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Glomerulonephritis, Membranous, this trial is ongoing. The trial is conducted by Azienda Ospedaliera Brotzu and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotRecruiting~Jun 2019 – ~May 2020 · 11 months · monthly snapshotActive Not Recruiting~May 2020 – ~Jan 2021 · 8 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotActive Not Recruiting~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown StatusUnknown

  3. Oct 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

    Status: Active Not RecruitingUnknown Status

  4. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE3

  5. May 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

Show 3 earlier versions
  1. Jun 2019 — May 2020 [monthly]

    Active Not Recruiting PHASE3

    Status: RecruitingActive Not Recruiting

  2. Jun 2018 — Jun 2019 [monthly]

    Recruiting PHASE3

  3. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Ospedaliera Brotzu
  • Azienda Ospedaliera Universitaria Policlinico
  • Azienda Sanitaria Locale Roma E
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
  • Fondazione Salvatore Maugeri
  • Humanitas Hospital, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Istituto Giannina Gaslini
  • Regione Piemonte
  • Universita di Verona
  • University of Alberta
  • University of Bari
  • University of Bern
  • University of Bologna
  • University of Chieti
  • University of Messina
  • University of Milan
  • University of Milano Bicocca
  • University of Modena and Reggio Emilia
  • University of Pisa
Data source: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations